Yan Wang

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Cardiovascular Disease

Top Venues

British journal of pharmacology

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Yan Wang, Jonathan Yodgee, Mark Del Borgo, Iresha Spizzo, Levi Nguyen, Marie-Isabel Aguilar, Kate M Denton, Chrishan S Samuel, Robert E Widdop
The Novel AT2 Receptor Agonist β-Pro7-AngIII Exerts Cardiac and Renal Anti-Fibrotic and Anti-Inflammatory Effects in High Salt-Fed Mice. International journal of molecular sciences 23 (22) (2022)
Chrishan S Samuel, Yifang Li, Yan Wang, Robert E Widdop
Functional crosstalk between angiotensin receptors (types 1 and 2) and relaxin family peptide receptor 1 (RXFP1): Implications for the therapeutic targeting of fibrosis. British journal of pharmacology (2022)
Chrishan S Samuel, Yifang Li, Yan Wang, Robert E Widdop
AT 1 R-AT 2 R-RXFP1 functional crosstalk: implications for the therapeutic targeting of fibrosis. British journal of pharmacology (2022)
Yan Wang, Miao Wang, Chrishan S Samuel, Robert E Widdop
Preclinical rodent models of cardiac fibrosis. British journal of pharmacology (2021)